Multiple sclerosis, which affects around one in 500 people in Switzerland, is an autoimmune disease in which immune cells ...
HealthDay on MSN
Menopause Not Tied to Worsening Multiple Sclerosis Disability
Menopause is not a leading factor for disability progression in women with multiple sclerosis (MS), according to a study ...
On track to initiate TRX319 Phase 1/2a dose-escalation trial in early 2026 TRX319 is an allogeneic CAR-Tr1 Treg cell therapy ...
Tr1X has won an FDA green light for a clinical trial testing TRX319, a cell therapy designed to restore immune balance, for ...
This is what we signed up for,” says Cary Lowe of caring for his wife Trish Butler. “For better or for worse, sickness and in health.” ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback